Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biolife Solutions (BLFS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 72,633
  • Shares Outstanding, K 13,230
  • Annual Sales, $ 8,230 K
  • Annual Income, $ -6,880 K
  • 36-Month Beta -0.81
  • Price/Sales 8.91
  • Price/Cash Flow 0.00
  • Price/Book 10.59

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.76 +21.22%
on 09/18/17
5.91 -2.37%
on 09/19/17
+0.92 (+18.97%)
since 09/15/17
3-Month
2.95 +95.59%
on 07/20/17
5.91 -2.37%
on 09/19/17
+2.24 (+63.46%)
since 07/17/17
52-Week
1.43 +303.50%
on 11/04/16
5.91 -2.37%
on 09/19/17
+4.11 (+247.59%)
since 10/17/16

Most Recent Stories

More News
BioLife Solutions CryoStor® Cell Freeze Media Embedded in Cellular Biomedicine Group Clinical Trial of AlloJoin(TM)

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media ("BioLife"),...

CBMG : 9.75 (-2.01%)
BLFS : 5.77 (+5.10%)
BioLife Solutions Announces Second Quarter 2017 Financial Results

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media ("BioLife" or...

BLFS : 5.77 (+5.10%)
BioLife Solutions to Report Second Quarter 2017 Financial Results and Provide Business Update on August 10, 2017

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media ("BioLife" or the "Company"),...

BLFS : 5.77 (+5.10%)
Featured Company News - BioLife Solutions Executes Supply Agreement with Celyad for CryoStor(R) Use in Natural Killer Receptor based T-Cell (NKR-T) Platform

Research Desk Line-up: Stryker Post Earnings Coverage

SYK : 148.79 (+1.02%)
CYAD : 62.33 (-0.23%)
BLFS : 5.77 (+5.10%)
BioLife Solutions Executes Supply Agreement with Celyad for CryoStor® Use in Natural Killer Receptor based T-Cell (NKR-T) Platform Targeting Solid Tumors and Blood Cancers

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media ("BioLife" or...

CYAD : 62.33 (-0.23%)
BLFS : 5.77 (+5.10%)
BioLife Solutions Modifies Existing Credit Facility

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media ("BioLife"), today...

BLFS : 5.77 (+5.10%)
BioLife Solutions Executes Supply Agreement with Adaptimmune for CryoStor® Use in SPEAR T-Cell Platform

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related...

BLFS : 5.77 (+5.10%)
ADAP : 7.01 (-4.37%)
BioLife Solutions Announces Q1 2017 Financial Results

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media ("BioLife" or...

BLFS : 5.77 (+5.10%)
BioLife Solutions to Report First Quarter 2017 Financial Results and Provide Business Update on May 11, 2017

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media ("BioLife" or the "Company"),...

BLFS : 5.77 (+5.10%)
BioLife Solutions to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Business Update on March 9, 2017

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media ("BioLife" or...

BLFS : 5.77 (+5.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of...

See More

Support & Resistance

2nd Resistance Point 6.02
1st Resistance Point 5.89
Last Price 5.77
1st Support Level 5.53
2nd Support Level 5.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart